These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27910812)

  • 21. The pathophysiology of abdominal aortic aneurysm growth: corresponding and discordant inflammatory and proteolytic processes in abdominal aortic and popliteal artery aneurysms.
    Abdul-Hussien H; Hanemaaijer R; Kleemann R; Verhaaren BF; van Bockel JH; Lindeman JH
    J Vasc Surg; 2010 Jun; 51(6):1479-87. PubMed ID: 20488324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of Fibulin-5 is associated with aortic dilation: role of inflammation and epigenetics.
    Orriols M; Varona S; Martí-Pàmies I; Galán M; Guadall A; Escudero JR; Martín-Ventura JL; Camacho M; Vila L; Martínez-González J; Rodríguez C
    Cardiovasc Res; 2016 Jun; 110(3):431-42. PubMed ID: 27089918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytokine metabolism in aneurysms of the abdominal aorta].
    Treska V; Topolcan O; Wenham PW; Pecen L; Kocová J
    Rozhl Chir; 1998 May; 77(5):225-9. PubMed ID: 9721555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abdominal aortic aneurysm rupture is not associated with an up-regulation of inflammation within the aneurysm wall.
    Wilson WR; Wills J; Furness PN; Loftus IM; Thompson MM
    Eur J Vasc Endovasc Surg; 2010 Aug; 40(2):191-5. PubMed ID: 20537568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokines that activate proteolysis are increased in abdominal aortic aneurysms.
    Newman KM; Jean-Claude J; Li H; Ramey WG; Tilson MD
    Circulation; 1994 Nov; 90(5 Pt 2):II224-7. PubMed ID: 7955258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of markers of inflammation, coagulation and vasoconstriction during follow-up of abdominal aortic aneurysms.
    Flondell-Sité D; Lindblad B; Gottsäter A
    Int Angiol; 2012 Jun; 31(3):276-82. PubMed ID: 22634983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ApoA-I/HDL-C levels are inversely associated with abdominal aortic aneurysm progression.
    Burillo E; Lindholt JS; Molina-Sánchez P; Jorge I; Martinez-Pinna R; Blanco-Colio LM; Tarin C; Torres-Fonseca MM; Esteban M; Laustsen J; Ramos-Mozo P; Calvo E; Lopez JA; Vega de Ceniga M; Michel JB; Egido J; Andrés V; Vazquéz J; Meilhac O; Martin-Ventura JL
    Thromb Haemost; 2015 Jun; 113(6):1335-46. PubMed ID: 25789510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory mediators are associated with 1-year mortality in critical limb ischemia.
    Barani J; Nilsson JA; Mattiasson I; Lindblad B; Gottsäter A
    J Vasc Surg; 2005 Jul; 42(1):75-80. PubMed ID: 16012455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study.
    Persson M; Engström G; Björkbacka H; Hedblad B
    Atherosclerosis; 2012 Feb; 220(2):502-5. PubMed ID: 22119508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative HDL Proteomics Identifies Peroxiredoxin-6 as a Biomarker of Human Abdominal Aortic Aneurysm.
    Burillo E; Jorge I; Martínez-López D; Camafeita E; Blanco-Colio LM; Trevisan-Herraz M; Ezkurdia I; Egido J; Michel JB; Meilhac O; Vázquez J; Martin-Ventura JL
    Sci Rep; 2016 Dec; 6():38477. PubMed ID: 27934969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abdominal aortic aneurysm and aortic occlusive disease: a comparison of risk factors and inflammatory response.
    Shteinberg D; Halak M; Shapiro S; Kinarty A; Sobol E; Lahat N; Karmeli R
    Eur J Vasc Endovasc Surg; 2000 Nov; 20(5):462-5. PubMed ID: 11112466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis and meta-regression analysis of biomarkers for abdominal aortic aneurysm.
    Stather PW; Sidloff DA; Dattani N; Gokani VJ; Choke E; Sayers RD; Bown MJ
    Br J Surg; 2014 Oct; 101(11):1358-72. PubMed ID: 25131707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monocyte count-to-high-density lipoprotein-cholesterol ratio is associated with abdominal aortic aneurysm size.
    Cagli K; Tok D; Turak O; Gunertem E; Yayla C; Lafci G; Ulas MM; Cagli K
    Biomark Med; 2016 Oct; 10(10):1039-1047. PubMed ID: 27626503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of transglutaminase type 2 for aortic wall protection in a rat abdominal aortic aneurysm formation.
    Munezane T; Hasegawa T; Suritala ; Tanaka A; Okada K; Okita Y
    J Vasc Surg; 2010 Oct; 52(4):967-74. PubMed ID: 20615646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transglutaminase type 2 in human abdominal aortic aneurysm is a potential factor in the stabilization of extracellular matrix.
    Shin S; Cho YP; Jun H; Park H; Hong HN; Kwon TW
    J Vasc Surg; 2013 May; 57(5):1362-70. PubMed ID: 23538006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated tissue plasminogen activator in patients with screening-detected abdominal aortic aneurysm.
    Wanhainen A; Nilsson TK; Bergqvist D; Boman K; Björck M
    J Vasc Surg; 2007 Jun; 45(6):1109-13. PubMed ID: 17543671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationships between activators and inhibitors of plasminogen, and the progression of small abdominal aortic aneurysms.
    Lindholt JS; Jørgensen B; Shi GP; Henneberg EW
    Eur J Vasc Endovasc Surg; 2003 Jun; 25(6):546-51. PubMed ID: 12787697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Change in smoking habits after having been screened for abdominal aortic aneurysm.
    Bohlin S; Fröjd C; Wanhainen A; Björck M
    Eur J Vasc Endovasc Surg; 2014 Aug; 48(2):138-43. PubMed ID: 24878236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endovascular aneurysm repair reverses the increased titer and the inflammatory activity of interleukin-1α in the serum of patients with abdominal aortic aneurysm.
    Yates CM; Abdelhamid M; Adam DJ; Nash GB; Bradbury AW; Rainger GE
    J Vasc Surg; 2011 Aug; 54(2):497-503. PubMed ID: 21620624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization.
    Kaneko H; Anzai T; Morisawa M; Kohno T; Nagai T; Anzai A; Takahashi T; Shimoda M; Sasaki A; Maekawa Y; Yoshimura K; Aoki H; Tsubota K; Yoshikawa T; Okada Y; Ogawa S; Fukuda K
    Atherosclerosis; 2011 Aug; 217(2):350-7. PubMed ID: 21530968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.